Today Ohioans Against the Deceptive Rx Ballot Issue announced opposition to the ballot issue on drug pricing in Ohio. More than 30,000 doctors, nurses and pharmacists, business and labor and the state’s largest organization serving individuals with AIDS/HIV announced their opposition to the proposal.
A policy report was released in September 2016, providing an analysis of the impact of the ballot issue on state programs, other local government entities and businesses. Vorys Health Care Advisors (VHCA) and Health Management Associates (HMA), analyzed the proposed initiated statute. The research team was led by VHCA President Maureen Corcoran and Barbara Coulter Edwards, Managing Principal with HMA, both well-known in the health care field with extensive experience in Medicaid.
The proposed initiated statute seeks to prohibit the state from entering into contracts where the “net cost” of a prescription drug purchased by the state is more than the “lowest price paid” by the U.S. Department of Veterans Affairs (VA).
If adopted, the proposed statute would affect roughly 4 million Ohioans. In addition to Ohio Medicaid, the state retirement systems and certain programs operated by state departments, the report also describes potential negative impacts on entities outside of state government, e.g. state universities and community colleges, the RxOC purchasing collaborative, BestRx, and concerns about access to VA-administered drugs now available to military veterans.
Click here to download the full report.